|
1PZQ
Structure of fused docking domains from the erythromycin polyketide synthase (DEBS), a model for the interaction between DEBS 2 and DEBS 3: The A domain
Deposited 2003-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3490–3547(58 aa)
Fragment:C-terminal fragment
Chain B
3490–3547(58 aa)
Fragment:C-terminal fragment
|
Mutation:L1G, F2S
Mutation:L1G, F2S
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Ionic strength (raw mmCIF value) 100mM phosphate buffer NA;Pressure ambient
NMR sample composition
1mM DOCK23 U-15N,13C: 100mM phosphate buffer NA: trace amounts of sodium azide, AEBSF protease inhibitor cocktail and TSP 1H shift reference: 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1mM DOCK23 (50% U-15N,13C: 50% unlabeled): 100mM phosphate buffer NA: trace amounts of sodium azide, AEBSF protease inhibitor cocktail and TSP 1H shift reference: 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
1PZR
Structure of fused docking domains from the erythromycin polyketide synthase (DEBS), a model for the interaction between DEBS2 and DEBS3: the B domain
Deposited 2003-07-14
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3548–3567(20 aa)
Fragment:RESIDUES 61-120
Chain B
3548–3567(20 aa)
Fragment:RESIDUES 61-120
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Ionic strength (raw mmCIF value) 100mM phosphate buffer NA;Pressure ambient
NMR sample composition
1mM DOCK23 U-15N,13C: 100mM phosphate buffer NA: trace amounts of sodium azide, AEBSF protease inhibitor cocktail and TSP 1H shift reference: 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1mM DOCK23 (50% U-15N,13C: 50% unlabeled): 100mM phosphate buffer NA: trace amounts of sodium azide, AEBSF protease inhibitor cocktail and TSP 1H shift reference: 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
3EL6
Crystal Structure of the Erythromycin Dehydratase
Deposited 2008-09-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2362–2653(292 aa)
Fragment:EryDH4 (UNP residues 2362 to 2653)
|
Not recorded
|
SO4 SULFATE ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;2.15 M ammonium sulfate, 100 mM sodium cacodylate pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 1.85 Å
R-free 0.227
|
|
6C9U
Crystal structure of [KS3][AT3] didomain from module 3 of 6-deoxyerthronolide B synthase in complex with antibody fragment (Fab)
Deposited 2018-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
2–922(921 aa)
Fragment:[KS3][AT3] didomain from module 3
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
K POTASSIUM ION × 2
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;285 K;200 mM potassium citrate, 20%(w/v) PEG 3,350 and 12% ethylene glycol)
|
Resolution 2.09 Å
R-free 0.210
|
|
7M7E
6-Deoxyerythronolide B synthase (DEBS) hybrid module (M3/1) in complex with antibody fragment 1B2
Deposited 2021-03-28
|
Different construct
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–922(921 aa)
Fragment:EryA2 (UNP residues 2-922) + EryA1 (UNP residues 1457-2015) + EryA3 (UNP residues 2896-3172)
Chain B
2–922(921 aa)
Fragment:EryA2 (UNP residues 2-922) + EryA1 (UNP residues 1457-2015) + EryA3 (UNP residues 2896-3172)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
7S6C
CryoEM structure of modular PKS holo-Lsd14 stalled at the condensation step and bound to antibody fragment 1B2, composite structure
Deposited 2021-09-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
2–30(29 aa)
Chain B
2–30(29 aa)
Chain C
2–30(29 aa)
Chain D
2–30(29 aa)
|
Not recorded
|
ATR 2'-MONOPHOSPHOADENOSINE-5'-DIPHOSPHATE × 1
PNS 4'-PHOSPHOPANTETHEINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Blot for 5 seconds before plunging in liquid ethane.
|
Resolution 3.10 Å
|
|
7S6D
CryoEM structure of modular PKS holo-Lsd14 bound to antibody fragment 1B2, composite structure
Deposited 2021-09-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
2–30(29 aa)
Chain B
2–30(29 aa)
Chain C
2–30(29 aa)
|
Not recorded
|
ATR 2'-MONOPHOSPHOADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Blot for 5 seconds before plunging in liquid ethane.
|
Resolution 3.10 Å
|